Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 21 (2020): Issue 1 (March 2020)
Open Access
Costs of Treatment of Severe COPD Exacerbation in Serbia
Radisa Pavlovic
Radisa Pavlovic
,
Svetlana Stojkov
Svetlana Stojkov
and
Zahida Binakaj
Zahida Binakaj
| Jun 05, 2020
Experimental and Applied Biomedical Research (EABR)
Volume 21 (2020): Issue 1 (March 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 05, 2020
Page range:
51 - 58
Received:
Dec 28, 2017
Accepted:
Feb 17, 2018
DOI:
https://doi.org/10.2478/sjecr-2018-0010
Keywords
COPD
,
severe exacerbation
,
hospitalization
,
costs
© 2020 Radisa Pavlovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Radisa Pavlovic
Faculty of Medical Science, University in Kragujevac
Kragujevac, Serbia
Svetlana Stojkov
Pharmaceutical Chamber of Serbia
Belgrade, Serbia
Zahida Binakaj
Pharmaceutical Chamber of Federation of Bosnia and Herzegovina
Sarajevo, Bosnia and Herzegovina